Mark R. Hake

Mark R. Hake

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

Bank of America Stock May Not Be All It’s Cracked Up to Be As Rates Fall

BAC stock may not be all it's cracked up to be. Investors in Bank of America may not be getting a great deal despite its rosy earnings.

IQiyi Is Headed for More Losses as Ad Sales Suffer From China Slowdown

IQiyi is headed for more losses and iQiyi stock will drop further. IQiyi gave a bleak outlook for Q3 amid the slowing Chinese economy.

Investors in Tesla Stock Should Take a Long-Term View

Investors should take a long term view with Tesla Stock. Tesla is in the EV market for the long haul, and so should investors in Tesla stock be as well.

Advanced Micro Devices Is Far Behind Competitors With Its 0% Total Yield

AMD stock has a 0% total yield, far behind competitors. Investors in AMD's competitors receive dividends and benefit from share buybacks.

Aurora Cannabis Stock Will Likely Fall 90% to Tangible Book Value

Aurora Cannabis stock will likely fall 90% to tangible book value. Unless Aurora can get profitable soon, ACB stock will keep dropping.

American Express Stock Will Benefit From Stock Buybacks

American Express stock will benefit from stock buybacks. Higher dividends per share growth will boost AXP stock over time.

With Profitability Nowhere in Sight, Tilray Stock Has Further to Fall

Tilray stock tumbles as investors demand profitability. Tilray, like other cannabis stocks, is stuck in a death spiral as long as the copmany can't produce profits.

Why Buy Overvalued Square Stock When It Hasn’t Performed?

Why buy overvalued Square stock when it hasn't performed? Square stock trades at high valuations but the stock has gone nowhere this year.

Johnson and Johnson Stock Still Significantly Undervalued

Johnson and Johnson stock still significantly undervalued. JNJ has the financial strength to cover capital returns and any legal settlements.

5 Excellent High-Yield Dividend Stocks to Buy

These are five high-yield stocks with well-covered dividends and low P/E ratios. Investors get paid to wait for their prices to rise.